The Northern California Family Registry, the leader of Research Module 3, proposes to enrich the Cooperative Family Registry of Breast Cancer Studies (CFRBCS) with additional minority families. Of the over 5,000 families currently enrolled in the CFRBCS, about 12% are minorities, most of which were recruited in the San Francisco Bay area. In collaboration with all Family Registries participating in the CFRBCS (except Australia) and a new Family Registry to be established in Southern California, an additional 1,700 population-based and 550 clinic- based minority families will be added to CFRBCS, including African- Americans, Hispanics, Chinese, Japanese and Filipinos. Using the protocols and questionnaires developed for the current CFRBCS, each Registry will continue the collection of family history, epidemiological, diet, treatment, and follow-up data and biospecimens such as blood or mouthwash samples and tumor blocks. BRCA1 and BRCA2 mutation testing will be performed at each Registry.
The specific aims of the proposed Research Module 3 are to: (1) estimate the prevalence of BRCA1 and BRCA2 mutations in each racial/ethnic group and identify the spectrum of mutations (including founder mutations) in population- based samples of breast cancer patients; (2) estimate the risk of breast cancer among BRCA1 and BRCA2 mutation carriers (penetrance); (3) contribute minority families to the CFRBCS to support the research proposed by the other Modules; and (4) contribute the minority families to the CFRBCS to support the research proposed by the other Modules; and (4) contribute the minority families to the CFRBCS for future collaborative studies. The Northern California Family Registry will recruit an additional 1,060 minority families t o bring the total number of minority families enrolled in CFRBCS by the year 2005 to 3,000, including 2,300 population-based and 700 clinic-based families. CFRBCS will be the largest resource ever assembled to support genetic and molecular research of breast cancer in minority families. Such an effort is unprecedented and unique, as no single center would ever be able to assemble such large numbers of minority from five racial/ethnic groups.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project--Cooperative Agreements (U01)
Project #
2U01CA069417-07
Application #
6481784
Study Section
Special Emphasis Panel (ZCA1)
Project Start
1995-09-30
Project End
2006-11-30
Budget Start
Budget End
Support Year
7
Fiscal Year
2001
Total Cost
Indirect Cost
Name
Northern California Cancer Center
Department
Type
DUNS #
City
Fremont
State
CA
Country
United States
Zip Code
94538
Block, Matthew S; Vierkant, Robert A; Rambau, Peter F et al. (2018) MyD88 and TLR4 Expression in Epithelial Ovarian Cancer. Mayo Clin Proc 93:307-320
Earp, Madalene; Tyrer, Jonathan P; Winham, Stacey J et al. (2018) Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility. PLoS One 13:e0197561
Lu, Yingchang; Beeghly-Fadiel, Alicia; Wu, Lang et al. (2018) A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk. Cancer Res 78:5419-5430
Peres, Lauren C; Risch, Harvey; Terry, Kathryn L et al. (2018) Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies. Int J Epidemiol 47:460-472
Ong, Jue-Sheng; Hwang, Liang-Dar; Cuellar-Partida, Gabriel et al. (2018) Assessment of moderate coffee consumption and risk of epithelial ovarian cancer: a Mendelian randomization study. Int J Epidemiol 47:450-459
Reid, Brett M; Permuth, Jennifer B; Chen, Y Ann et al. (2017) Integration of Population-Level Genotype Data with Functional Annotation Reveals Over-Representation of Long Noncoding RNAs at Ovarian Cancer Susceptibility Loci. Cancer Epidemiol Biomarkers Prev 26:116-125
Kar, Siddhartha P; Adler, Emily; Tyrer, Jonathan et al. (2017) Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci. Br J Cancer 116:524-535
Ovarian Tumor Tissue Analysis (OTTA) Consortium; Goode, Ellen L; Block, Matthew S et al. (2017) Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer. JAMA Oncol 3:e173290
Dite, Gillian S; MacInnis, Robert J; Bickerstaffe, Adrian et al. (2017) Testing for Gene-Environment Interactions Using a Prospective Family Cohort Design: Body Mass Index in Early and Later Adulthood and Risk of Breast Cancer. Am J Epidemiol 185:487-500
Barrdahl, Myrto; Rudolph, Anja; Hopper, John L et al. (2017) Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium. Int J Cancer 141:1830-1840

Showing the most recent 10 out of 159 publications